1. Home
  2. GNSS vs ANIX Comparison

GNSS vs ANIX Comparison

Compare GNSS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genasys Inc.

GNSS

Genasys Inc.

N/A

Current Price

$1.83

Market Cap

101.7M

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$2.86

Market Cap

104.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GNSS
ANIX
Founded
1992
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.7M
104.0M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
GNSS
ANIX
Price
$1.83
$2.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.50
$9.00
AVG Volume (30 Days)
135.7K
95.1K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
44.44
12.82
EPS
N/A
N/A
Revenue
$26,306,790.00
$210,000.00
Revenue This Year
$78.94
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
29.50
N/A
52 Week Low
$1.46
$2.33
52 Week High
$2.70
$5.46

Technical Indicators

Market Signals
Indicator
GNSS
ANIX
Relative Strength Index (RSI) 42.86 45.57
Support Level $1.52 $2.74
Resistance Level $1.85 $3.11
Average True Range (ATR) 0.11 0.16
MACD -0.01 0.01
Stochastic Oscillator 35.18 35.00

Price Performance

Historical Comparison
GNSS
ANIX

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: